Literature DB >> 8314980

Characterization of Brevibacterium spp. from clinical specimens.

E Gruner1, G E Pfyffer, A von Graevenitz.   

Abstract

Nonfermenting coryneform bacteria identified as Brevibacterium spp. were isolated from routine clinical specimens. Four strains were derived from peritoneal fluid and has presumably been involved in the pathogenesis of continuous ambulatory peritoneal dialysis peritonitis. Another five isolates most probably represented skin contaminants. Cell wall and lipid analyses confirmed the genus identification. Strains in this taxon are difficult to distinguish from other biochemically inactive and nonmotile coryneform species but show characteristics cellular fatty acid profiles. In vitro susceptibilities to commonly used antibiotics were determined.

Entities:  

Mesh:

Year:  1993        PMID: 8314980      PMCID: PMC265552          DOI: 10.1128/jcm.31.6.1408-1412.1993

Source DB:  PubMed          Journal:  J Clin Microbiol        ISSN: 0095-1137            Impact factor:   5.948


  6 in total

1.  Central venous line infection caused by Brevibacterium epidermidis.

Authors:  C McCaughey; N N Damani
Journal:  J Infect       Date:  1991-09       Impact factor: 6.072

Review 2.  Production of volatile sulfur compounds by microorganisms.

Authors:  H Kadota; Y Ishida
Journal:  Annu Rev Microbiol       Date:  1972       Impact factor: 15.500

Review 3.  Cell wall composition in the classification and identification of coryneform bacteria.

Authors:  R M Keddie; I J Bousfield
Journal:  Soc Appl Bacteriol Symp Ser       Date:  1980

4.  Identification of Brevibacterium from clinical sources.

Authors:  D G Pitcher; H Malnick
Journal:  J Clin Pathol       Date:  1984-12       Impact factor: 3.411

5.  Cellular fatty acid composition as an adjunct to the identification of asporogenous, aerobic gram-positive rods.

Authors:  K A Bernard; M Bellefeuille; E P Ewan
Journal:  J Clin Microbiol       Date:  1991-01       Impact factor: 5.948

Review 6.  Microbiological aspects of peritonitis associated with continuous ambulatory peritoneal dialysis.

Authors:  A von Graevenitz; D Amsterdam
Journal:  Clin Microbiol Rev       Date:  1992-01       Impact factor: 26.132

  6 in total
  12 in total

1.  Relapsing Brevibacterium casei peritonitis: value of 16S rRNA gene sequencing in accurate species identification.

Authors:  Koen Poesen; Gert Meeus; Michaël Boudewijns; Johan Colaert; Peter Doubel
Journal:  Perit Dial Int       Date:  2012 May-Jun       Impact factor: 1.756

2.  Primary identification of Microbacterium spp. encountered in clinical specimens as CDC coryneform group A-4 and A-5 bacteria.

Authors:  G Funke; E Falsen; C Barreau
Journal:  J Clin Microbiol       Date:  1995-01       Impact factor: 5.948

3.  Peritonitis due to Brevibacterium otitidis in a patient undergoing continuous ambulatory peritoneal dialysis.

Authors:  G Wauters; B Van Bosterhaut; V Avesani; R Cuvelier; J Charlier; M Janssens; M Delmée
Journal:  J Clin Microbiol       Date:  2000-11       Impact factor: 5.948

Review 4.  Clinical microbiology of coryneform bacteria.

Authors:  G Funke; A von Graevenitz; J E Clarridge; K A Bernard
Journal:  Clin Microbiol Rev       Date:  1997-01       Impact factor: 26.132

5.  Post-traumatic endophthalmitis due to Brevibacterium casei : A case report.

Authors:  Asima Banu; Sriprakash Ks; Vidyadevi M; Nagraj Er
Journal:  Australas Med J       Date:  2013-02-28

6.  Cultivable internal bacterial flora of ticks isolated in Hungary.

Authors:  László Egyed; László Makrai
Journal:  Exp Appl Acarol       Date:  2013-12-24       Impact factor: 2.132

7.  Differentiation of Brevibacterium spp. encountered in clinical specimens.

Authors:  G Funke; A Carlotti
Journal:  J Clin Microbiol       Date:  1994-07       Impact factor: 5.948

8.  Recurrent bacteremia due to Brevibacterium casei in an immunocompromised patient.

Authors:  R R Reinert; N Schnitzler; G Haase; R Lütticken; U Fabry; K P Schaal; G Funke
Journal:  Eur J Clin Microbiol Infect Dis       Date:  1995-12       Impact factor: 3.267

9.  Bacteremia caused by Brevibacterium species in an immunocompromised patient.

Authors:  S S Kaukoranta-Tolvanen; A Sivonen; A A Kostiala; P Hormila; M Vaara
Journal:  Eur J Clin Microbiol Infect Dis       Date:  1995-09       Impact factor: 3.267

10.  Human infections caused by Brevibacterium casei, formerly CDC groups B-1 and B-3.

Authors:  E Gruner; A G Steigerwalt; D G Hollis; R S Weyant; R E Weaver; C W Moss; M Daneshvar; J M Brown; D J Brenner
Journal:  J Clin Microbiol       Date:  1994-06       Impact factor: 5.948

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.